JAN
Q3 2026 EPS Estimate
$0.05
Sep 2, 2026
Revenue Estimate
$218M
FY2026E EPS$0.18
FY2027E EPS$0.22

Analyst Sentiment

Wall St. Consensus
Buy
6 analysts·Limited coverage
75
Score
6 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
6100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$27.00
-14.5%
Consensus
$29.50
-6.6%
Bull
$34.00
+7.6%
12-Month Target Range6 analysts
$27.00$29.50$34.00
Current $31.59Consensus
Current Price
$31.59
Above Consensus
$2.09

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+22.19%
EPS+20.03%
FY2028
Rev+34.00%
EPS-19.69%
FY2029
Rev+4.14%
EPS+151.43%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$889M$1.09B$1.46B$1.52B$1.67B
Low$863M$826M$918M$1.21B$1.33B
High$938M$1.42B$1.85B$1.88B$2.06B
EBITDA Avg$183M$223M$299M$311M$342M
Low$177M$170M$188M$249M$274M
High$193M$291M$380M$385M$423M
EBIT Avg$-86M$-104M$-140M$-146M$-160M
Low$-90M$-136M$-178M$-180M$-198M
High$-83M$-79M$-88M$-117M$-128M
Net Income Avg$33M$39M$32M$80M$94M
Low$32M$36M$23M$59M$70M
High$34M$41M$41M$104M$123M
EPS Avg$0.18$0.22$0.17$0.44$0.52
Low$0.18$0.20$0.13$0.33$0.39
High$0.19$0.23$0.23$0.58$0.68
Analysts (Rev / EPS)7 / 27 / 35 / 12 / 12 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$233M$248M$259M$265M$274M$283M$336M$348M
Low$186M$208M$218M$222M$230M$238M$282M$292M
High$271M$286M$300M$307M$317M$328M$388M$403M
EBITDA Avg$48M$51M$53M$54M$56M$58M$69M$71M
Low$38M$43M$45M$46M$47M$49M$58M$60M
High$56M$59M$62M$63M$65M$67M$80M$83M
EBIT Avg$-22M$-24M$-25M$-25M$-26M$-27M$-32M$-33M
Low$-26M$-28M$-29M$-29M$-30M$-32M$-37M$-39M
High$-18M$-20M$-21M$-21M$-22M$-23M$-27M$-28M
Net Income Avg$6M$7M$11M$11M$11M$12M
Low$6M$6M$9M$9M$9M$10M
High$7M$9M$14M$14M$14M$15M
EPS Avg$0.03$0.04$0.06$0.06$0.06$0.07
Low$0.03$0.03$0.05$0.05$0.05$0.05
High$0.04$0.05$0.07$0.07$0.07$0.08
Analysts (Rev / EPS)5 / 32 / 12 / 12 / 12 / 12 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Jul 15, 2026Wells Fargo
Janus Living price target raised to $33 from $31 at Wells Fargo
Target:$33.00
+11.6%from $29.56
Jul 7, 2026Barclays
Janus Living price target raised to $33 from $30 at Barclays
Target:$33.00
+12.3%from $29.38
Jun 18, 2026UBS
Janus Living price target lowered to $29 from $30 at Scotiabank
Target:$29.00
+14.3%from $25.38
Jun 16, 2026Raymond James
Janus Living initiated with a Strong Buy at Raymond James
Target:$34.00
+34.0%from $25.37
Jun 10, 2026KeyBanc
Janus Living price target raised to $29 from $28 at KeyBanc
Target:$29.00
+14.1%from $25.42
May 27, 2026Scotiabank
Janus Living price target raised to $30 from $28 at Scotiabank
Target:$30.00
+10.6%from $27.12
May 13, 2026Barclays
Janus Living price target raised to $30 from $26 at Barclays
Target:$30.00
+11.0%from $27.02
May 8, 2026RBC Capital
Janus Living price target raised to $30 from $27 at RBC Capital
Target:$30.00
+7.2%from $27.99
Apr 14, 2026Scotiabank
Janus Living initiated with an Outperform at Scotiabank
Target:$28.00
+13.6%from $24.65
Apr 14, 2026Goldman Sachs
Janus Living initiated with a Neutral at Goldman Sachs
Target:$27.00
+12.5%from $23.99
Apr 14, 2026BNP Paribas
Janus Living initiated with an Outperform at BNP Paribas
Target:$27.00
+12.5%from $23.99
Apr 14, 2026Wells Fargo
Janus Living initiated with an Overweight at Wells Fargo
Target:$27.00
+12.5%from $23.99
Apr 14, 2026RBC Capital
Janus Living initiated with an Outperform at RBC Capital
Target:$27.00
+12.5%from $23.99
Apr 14, 2026Morgan Stanley
Janus Living initiated with an Overweight at Morgan Stanley
Target:$28.00
+16.7%from $23.99
Apr 14, 2026KeyBanc
Janus Living initiated with an Overweight at KeyBanc
Target:$28.00
+16.7%from $23.99
Apr 14, 2026Barclays
Janus Living initiated with an Overweight at Barclays
Target:$26.00
+8.4%from $23.99
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.